However, PFDN1, 3, and 5 are not present in the Uri-complex, showing that the detected clinical effects in LC are mediated by canonical PFDN, likely mediated by its nuclear role acting on cyclin A expression, as proposed by Wang et al. [8]. This evidence concerns the gene CCNA2 and laryngotracheoesophageal cleft.